Safety and Efficacy of Lumiracoxib Versus Naproxen in Acute Musculoskeletal Pain
NCT00170898
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
419
Enrollment
INDUSTRY
Sponsor class
Conditions
Musculoskeletal Pain
Interventions
DRUG:
Lumiracoxib
Sponsor
Novartis